Exclusive and Combined Use of Statins and Aspirin and the Risk of Pancreatic Cancer: a Case-Control Study

Data on the association between aspirin and statin use and Pancreatic Ductal AdenoCarcinoma (PDAC) risk are conflicting. These drugs are often co-prescribed, but no studies evaluated the potential combined or confounding effect of the two at the same time. We aimed to investigate the association bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Archibugi, Livia, Piciucchi, Matteo, Stigliano, Serena, Valente, Roberto, Zerboni, Giulia, Barucca, Viola, Milella, Michele, Maisonneuve, Patrick, Delle Fave, Gianfranco, Capurso, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638859/
https://www.ncbi.nlm.nih.gov/pubmed/29026148
http://dx.doi.org/10.1038/s41598-017-13430-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638859/
https://www.ncbi.nlm.nih.gov/pubmed/29026148
http://dx.doi.org/10.1038/s41598-017-13430-z

Ejemplares similares